Aequus Pharmaceuticals (AQS) News Today → Biden replacement revealed? (From Paradigm Press) (Ad) Free AQS Stock Alerts C$0.02 -0.01 (-25.00%) (As of 04/17/2024) Add Compare Share Share HeadlinesStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAQS:CA Aequus Pharmaceuticals Inc.seekingalpha.com - April 20 at 12:31 AMZoomd Technologies: Top 10 Undervalued Growth Stocks on TSX-V (ZOMD)theglobeandmail.com - February 23 at 11:53 PMAequus Pharmaceuticals: Top 10 Undervalued Drug Manufacturers Industry Stocks (AQS)theglobeandmail.com - February 18 at 2:13 PMAequus Pharmaceuticals Inc AQSmorningstar.com - December 12 at 3:39 PMAequus Pharmaceuticals reports Q3 resultsmsn.com - November 30 at 11:53 AMClosing Bell: Aequus Pharmaceuticals Inc up on Thursday (AQS)theglobeandmail.com - October 18 at 10:50 PMClosing Bell: Aequus Pharmaceuticals Inc flat on Thursday (AQS)theglobeandmail.com - October 7 at 7:58 AMClosing Bell: Aequus Pharmaceuticals Inc flat on Tuesday (AQS)theglobeandmail.com - October 5 at 12:04 PMClosing Bell: Aequus Pharmaceuticals Inc flat on Friday (AQS)theglobeandmail.com - September 29 at 6:32 PMClosing Bell: Aequus Pharmaceuticals Inc flat on Wednesday (AQS)theglobeandmail.com - September 29 at 12:34 AMAequus Pharmaceuticals: Aequus Reports Second Quarter 2023 Financial Highlights and General Updatefinanznachrichten.de - August 30 at 5:10 AMAequus Reports Second Quarter 2023 Financial Highlights and General Updatemarkets.businessinsider.com - August 29 at 11:22 PMClosing Bell: Aequus Pharmaceuticals Inc up on Wednesday (AQS)theglobeandmail.com - August 25 at 11:16 PMAequus Announces Zimed PF Now Available in Canadafinance.yahoo.com - August 24 at 9:56 AMAequus Announces Zimed PF Website Launchfinance.yahoo.com - August 22 at 10:20 AMAequus Pharmaceutical Canada Announces a Pause in Sales of Evolve Intensive Eyedrops and Gel in Canadafinance.yahoo.com - August 18 at 8:32 AMAequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%)benzinga.com - July 6 at 8:57 PMAQS.V - Aequus Pharmaceuticals Inc.ca.finance.yahoo.com - June 7 at 7:13 PMAequus Pharmaceuticals: Aequus Provides General Update and First Quarter 2023 Financial Highlightsfinanznachrichten.de - May 31 at 3:23 PMAequus Provides General Update and First Quarter 2023 Financial Highlightsfinance.yahoo.com - May 31 at 12:45 AMAequus Provides General Update and Fiscal 2022 Financial Resultsfinance.yahoo.com - May 2 at 12:47 AMAequus Grants Stock Optionsfinance.yahoo.com - April 19 at 6:45 PMAequus Announces Financing to Support Launch of Zimed Preservative Free (Bimatoprost 0.03%) and Board Updatefinance.yahoo.com - April 5 at 9:15 AMAequus Pharmaceuticals Inc. (AQS.V)finance.yahoo.com - March 26 at 5:31 PMAequus Announces Health Canada Notice of Compliance (NOC) for Zimed® Preservative Free (Bimatoprost 0.03%)finance.yahoo.com - December 20 at 12:49 PMAequus Pharmaceuticals Third Quarter 2022 Earnings: CA$0.004 loss per share (vs CA$0.003 loss in 3Q 2021)yahoo.com - December 3 at 7:25 AMAequus Pharmaceuticals: Aequus Reports Third Quarter 2022 Financial Highlightsfinanznachrichten.de - November 30 at 10:49 AMAequus Reports Third Quarter 2022 Financial Highlightsfinance.yahoo.com - November 30 at 10:49 AMAequus Announces Sandoz Contract Expiry at Year End and Expected Health Canada Approval for Zimed® PF (Preservative Free)finance.yahoo.com - November 29 at 8:58 AMAequus Pharmaceuticals Increuters.com - October 9 at 9:56 AMAequus Pharmaceuticals reports Q2 resultsseekingalpha.com - August 30 at 3:36 AMAequus Reports Second Quarter 2022 Financial Highlights and General Updatefinance.yahoo.com - August 29 at 10:24 PMIIROC Trading Resumption - AQSfinance.yahoo.com - July 13 at 6:29 PMAequus Resumes Trading on TSX Venture Exchangefinance.yahoo.com - July 13 at 6:29 PMAequus Provides General Update and Reports Record 2021 Financial Resultsfinancialpost.com - July 1 at 6:19 PMAequus Provides Update on Delay in Filing Annual Financial Statementsstockhouse.com - May 7 at 12:27 AMIIROC Trading Halt - AQS.WTfinance.yahoo.com - May 2 at 4:20 PMIIROC Trading Halt - AQS.DBfinance.yahoo.com - May 2 at 11:19 AMAequus Announces Short Term Loanstockhouse.com - May 2 at 11:19 AMAequus Announces Director Resignationbenzinga.com - April 22 at 5:04 PMSandoz and Aequus Agree to 1-Year Extension on Vistitan in Canadafinance.yahoo.com - January 11 at 5:40 PMAequus Announces Canadian Filing of NDS for Preservative-Free Glaucoma Medicationfinance.yahoo.com - January 6 at 12:05 PMIs Aequus Pharmaceuticals (CVE:AQS) Weighed On By Its Debt Load?ca.finance.yahoo.com - November 5 at 2:21 PMAequus Reports Third Quarter 2021 Financial Highlightsapnews.com - November 3 at 9:26 AMAequus Reports Second Quarter 2021 Financial Highlightsstockhouse.com - August 30 at 9:35 AMAequus Strengthens Clinical Experience in Stargardt Disease with Pediatric Ophthalmology Expertisefinance.yahoo.com - August 25 at 5:12 PMAequus and reVision to Collaborate on Stargardt Disease Programprnewswire.com - August 17 at 8:27 AM Get Aequus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AQS and its competitors with MarketBeat's FREE daily newsletter. Email Address One trade. One ticker. One week. (Ad)Do you want to target weekly income of up to $2k or more… Starting with just $500... With just one trade per week? Well, then you should click here to see this free training. AQS Media Mentions By Week AQS Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AQS News Sentiment▼0.000.43▲Average Medical News Sentiment AQS News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AQS Articles This Week▼10▲AQS Articles Average Week Get Aequus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for AQS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ENTG News Today VM News Today DN News Today SVS News Today EKG News Today HEM News Today IOT News Today QPT News Today TMD News Today VIV News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (CVE:AQS) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsThe #1 Biotech Stock to Have on Your Radar in 2024… Huge AlertsFed launches fourth dollar overhaulStansberry ResearchThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aequus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
